This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ravyn, M. D.
Right arrow Articles by Johnson, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ravyn, M. D.
Right arrow Articles by Johnson, R. C.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 1998, p. 1480-1488, Vol. 36, No. 6
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Immunodiagnosis of Human Granulocytic Ehrlichiosis by Using Culture-Derived Human Isolatesdagger

M. Dana Ravyn,1 Jesse L. Goodman,2 Carrie B. Kodner,1 Deborah K. Westad,1 Lisa A. Coleman,1 Suzanne M. Engstrom,1 Curt M. Nelson,2 and Russell C. Johnson1,*

Department of Microbiology1 and Division of Infectious Diseases, Department of Medicine,2 University of Minnesota Academic Health Center, Minneapolis, Minnesota 55455

Received 24 October 1997/Returned for modification 18 February 1998/Accepted 2 March 1998

Human granulocytic ehrlichiosis (HGE) is an emerging infection caused by an Ehrlichia species closely related to Ehrlichia equi and Ehrlichia phagocytophila. Recent advances in the isolation and cultivation of this organism have allowed us to develop an immunofluorescence assay (IFA), enzyme immunoassay (EIA), and Western immunoblotting (WB) using HL-60 cell culture-derived human isolates. Antibody was detected in sera from culture-confirmed HGE patients by IFA and EIA, and these samples were reactive when analyzed by immunoblot analysis. HGE patient sera had high antibody titers and did not react with uninfected HL-60 cells. When IFA, EIA, and WB were used to analyze sera from healthy donors or those with a range of other disorders, including infections caused by Ehrlichia chaffeensis, Rickettsia rickettsii, and Coxiella burnetti, no significant cross-reactivity could be detected by EIA or immunoblot analysis with the exception of two of four serum samples from R. rickettsii-infected patients that were reactive by IFA only. Sera from HGE patients did not significantly cross-react in serologic tests for Borrelia burgdorferi. Using sera from patients previously enrolled in two clinical trials of treatment for early Lyme disease, we evaluated a two-step approach for estimation of the seroprevalence of antibodies reactive with the etiologic agent of HGE. On the basis of the immunoblot assay results for sera from culture-confirmed HGE patients, WB was used to confirm the specificity of the antibody detected by EIA and IFA. EIA was found to be superior to IFA in the ability to detect WB-confirmed antibodies to the HGE agent. When EIA and WB were used, 56 (19.9%) patients with early Lyme disease (n = 281) had either specific immunoglobulin M (IgM) or IgG antibodies; 38 patients (13.5%) had IgM only, 6 (2.1%) had IgG only, and 12 (4.3%) had both IgM and IgG. Therefore, Lyme disease patients are at high potential risk for exposure to Ehrlichia. Analysis by immunoblotting of serial samples from persons with culture-confirmed HGE or patients with Lyme disease and antibodies to the agent of HGE revealed a reproducible pattern of the immune response to specific antigens. These samples confirmed the importance of the 42- to 45-kDa antigens as early, persistent, and specific markers of HGE infection. Other significant immunogenic proteins appear at 20, 21, 28, 30, and 60 kDa. Use of the two-test method of screening by EIA and confirming the specificity by WB appears to offer a sound approach to the clinical immunodiagnosis of HGE.

* Corresponding author. Mailing address: University of Minnesota, Academic Health Center, 420 Delaware St. S.E., Box 196 UMHC, Minneapolis, MN 55455-0312. Phone: (612) 624-5684. Fax: (612) 626-0623. E-mail: ravyn{at}lenti.med.umn.edu.

dagger This paper is dedicated to Mary C. Panghorn, the discoverer of cardiolipin, at the Division of Laboratories and Research, New York State Department of Health, Albany, New York, for her 90th birthday.

Journal of Clinical Microbiology, June 1998, p. 1480-1488, Vol. 36, No. 6
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Levin, M. L., Coble, D. J., Ross, D. E. (2004). Reinfection with Anaplasma phagocytophilum in BALB/c Mice and Cross-Protection between Two Sympatric Isolates. Infect. Immun. 72: 4723-4730 [Abstract] [Full Text]  
  • Heo, E.-j., Park, J.-h., Koo, J.-r., Park, M.-s., Park, M.-y., Dumler, J. S., Chae, J.-s. (2002). Serologic and Molecular Detection of Ehrlichia chaffeensis and Anaplasma phagocytophila (Human Granulocytic Ehrlichiosis Agent) in Korean Patients. J. Clin. Microbiol. 40: 3082-3085 [Abstract] [Full Text]  
  • Unver, A., Felek, S., Paddock, C. D., Zhi, N., Horowitz, H. W., Wormser, G. P., Cullman, L. C., Rikihisa, Y. (2001). Western Blot Analysis of Sera Reactive to Human Monocytic Ehrlichiosis and Human Granulocytic Ehrlichiosis Agents. J. Clin. Microbiol. 39: 3982-3986 [Abstract] [Full Text]  
  • Ravyn, M. D., Kodner, C. B., Carter, S. E., Jarnefeld, J. L., Johnson, R. C. (2001). Isolation of the Etiologic Agent of Human Granulocytic Ehrlichiosis from the White-Footed Mouse (Peromyscus leucopus). J. Clin. Microbiol. 39: 335-338 [Abstract] [Full Text]  
  • Tajima, T., Zhi, N., Lin, Q., Rikihisa, Y., Horowitz, H. W., Ralfalli, J., Wormser, G. P., Hechemy, K. E. (2000). Comparison of Two Recombinant Major Outer Membrane Proteins of the Human Granulocytic Ehrlichiosis Agent for Use in an Enzyme-Linked Immunosorbent Assay. CVI 7: 652-657 [Abstract] [Full Text]  
  • Aguero-Rosenfeld, M. E., Kalantarpour, F., Baluch, M., Horowitz, H. W., McKenna, D. F., Raffalli, J. T., Hsieh, T.-c., Wu, J., Dumler, J. S., Wormser, G. P. (2000). Serology of Culture-Confirmed Cases of Human Granulocytic Ehrlichiosis. J. Clin. Microbiol. 38: 635-638 [Abstract] [Full Text]  
  • Ijdo, J. W., Wu, C., Magnarelli, L. A., Fikrig, E. (1999). Serodiagnosis of Human Granulocytic Ehrlichiosis by a Recombinant HGE-44-Based Enzyme-Linked Immunosorbent Assay. J. Clin. Microbiol. 37: 3540-3544 [Abstract] [Full Text]  
  • Walls, J. J., Aguero-Rosenfeld, M., Bakken, J. S., Goodman, J. L., Hossain, D., Johnson, R. C., Dumler, J. S. (1999). Inter- and Intralaboratory Comparison of Ehrlichia equi and Human Granulocytic Ehrlichiosis (HGE) Agent Strains for Serodiagnosis of HGE by the Immunofluorescent-Antibody Test. J. Clin. Microbiol. 37: 2968-2973 [Abstract] [Full Text]  
  • Childs, J. E., Sumner, J. W., Nicholson, W. L., Massung, R. F., Standaert, S. M., Paddock, C. D. (1999). Outcome of Diagnostic Tests Using Samples from Patients with Culture-Proven Human Monocytic Ehrlichiosis: Implications for Surveillance. J. Clin. Microbiol. 37: 2997-3000 [Abstract] [Full Text]  
  • Comer, J. A., Nicholson, W. L., Olson, J. G., Childs, J. E. (1999). Serologic Testing for Human Granulocytic Ehrlichiosis at a National Referral Center. J. Clin. Microbiol. 37: 558-564 [Abstract] [Full Text]  
  • Magnarelli, L. A., Ijdo, J. W., Anderson, J. F., Padula, S. J., Flavell, R. A., Fikrig, E. (1998). Human Exposure to a Granulocytic Ehrlichia and Other Tick-Borne Agents in Connecticut. J. Clin. Microbiol. 36: 2823-2827 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»